Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview

Olopatadine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for olopatadine hydrochloride and what is the scope of olopatadine hydrochloride patent protection?

Olopatadine hydrochloride
is the generic ingredient in five branded drugs marketed by Somerset Theraps Llc, Zach System Spa, Aurobindo Pharma Ltd, Akorn Inc, Novartis Pharms Corp, Barr Labs Inc, Apotex Inc, Usv North America, and Perrigo Israel, and is included in thirteen NDAs. There are seven patents protecting this compound and four Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Olopatadine hydrochloride has fifty-one patent family members in twenty-three countries.

There are sixteen drug master file entries for olopatadine hydrochloride. Fourteen suppliers are listed for this compound. There are five tentative approvals for this compound.

Summary for Generic Name: olopatadine hydrochloride

Tradenames:5
Patents:7
Applicants:9
NDAs:13
Drug Master File Entries: see list16
Suppliers / Packagers: see list14
Bulk Api Vendors: see list73
Clinical Trials: see list995
Patent Applications: see list2,716
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:olopatadine hydrochloride at DailyMed

Pharmacology for Ingredient: olopatadine hydrochloride

Tentative approvals for OLOPATADINE HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe0.2% BASESOLUTION; OPHTHALMIC
► Subscribe► Subscribe0.1%SOLUTION; OPHTHALMIC
► Subscribe► Subscribe0.1%SOLUTION/DROPS; OPHTHALMIC
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc
OLOPATADINE HYDROCHLORIDE
olopatadine hydrochloride
SOLUTION/DROPS;OPHTHALMIC078350-001Dec 7, 2015ATRXNoNo► Subscribe► Subscribe
Akorn Inc
OLOPATADINE HYDROCHLORIDE
olopatadine hydrochloride
SOLUTION/DROPS;OPHTHALMIC204532-001Jan 10, 2017ATRXNoNo► Subscribe► Subscribe
Novartis Pharms Corp
PAZEO
olopatadine hydrochloride
SOLUTION/DROPS;OPHTHALMIC206276-001Jan 30, 2015RXYesYes9,533,053► SubscribeY ► Subscribe
Barr Labs Inc
OLOPATADINE HYDROCHLORIDE
olopatadine hydrochloride
SOLUTION/DROPS;OPHTHALMIC090848-001Jul 13, 2015ATRXNoNo► Subscribe► Subscribe
Somerset Theraps Llc
OLOPATADINE HYDROCHLORIDE
olopatadine hydrochloride
SOLUTION/DROPS;OPHTHALMIC206306-001Dec 7, 2015ATRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot